|
2010 Other Outputs Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compoundBlaskovich, Mark and CASSIDY P J (2010). Modulating activity of melanocortin-1 receptor, delivering active agent to melanocortin-1 receptor, and for treating condition e.g. hyperpigmentation, and pain involves exposing melanocortin-1 receptor to substituted (1,4)diazepane compound. WO2010096853-A1. |
|
2009 Other Outputs New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancersBLASKOVICH M A T and CASSIDY P J (2009). New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancers. WO2009105825-A1. |
|
2009 Other Outputs Use of 1,4-diazepan-2-one derivatives for down-regulating activity of melanocortin-5 receptor and treating, preventing or controlling a condition e.g. acne, and seborrheic dermatitisBLASKOVICH M A T and CASSIDY P J, (2009). Use of 1,4-diazepan-2-one derivatives for down-regulating activity of melanocortin-5 receptor and treating, preventing or controlling a condition e.g. acne, and seborrheic dermatitis. WO2009105824-A1. |
|
2009 Other Outputs New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancersBLASKOVICH M A T and CASSIDY P J (2009). New 1,4-diazepan-2-one derivatives useful for treating, preventing or controlling condition e.g. acne, seborrheic dermatitis, acne vulgaris, acne fulminans, inflammation, and cancers. WO2009105823-A1. |
|
2009 Other Outputs Protein tyrosine phosphatase inhibitors and methods of use thereofBlaskovich, Mark Arnold Thomas, Baughman, Ted, Little, Thomas, Patt, William, Qabar, Maher, Schultz, Lauri, Nagula, Gangadhar, Gage, Jennifer Lynn and Howbert, James Jeffry (2009). Protein tyrosine phosphatase inhibitors and methods of use thereof. US 07504389. |
|
2009 Other Outputs Protein Tyrosine Phosphatase Inhibitors and Methods of Use ThereofMark Arnold Thomas Blaskovich, Ted Baughman, Thomas Little, William Pratt, Maher Qabar, Laurie Marie Schultz, Gangadhar Nagula, Jennifer Lynn Gage and James Jeffry Howbert (2009). Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof. US7504389. |
|
2006 Other Outputs Protein tyrosine phosphatase inhibitors and methods of use thereofBlaskovich, Mark A., Little, Thomas, Qabar, Maher, Schultz, Lauri, Gage, Jennifer Lynn, Hong, Feng, Baughman, Ted, Patt, William, Howbert, James Jeffry and Nagula, Gangadhar (2006). Protein tyrosine phosphatase inhibitors and methods of use thereof. US2006142250(A1). |
|
2006 Other Outputs beta-sheet mimetics and composition and methods relating theretoBlaskovich, Mark A., Ogbu, Cyprian, O. and Kim, Hwa-Ok (2006). beta-sheet mimetics and composition and methods relating thereto. US7053214(B2). |
|
2006 Other Outputs Protein tyrosine pPhosphatase inhibitors and methods of use thereofBlaskovich, Mark A., Baughman, Ted, Little, Thomas, Patt, William, Qabar, Maher, Schultz, Lauri, Hong, Feng, Nagula, Gangadhar, Gage, Jennifer Lynn and Howbert, James Jeffry (2006). Protein tyrosine pPhosphatase inhibitors and methods of use thereof. WO/2006/055525. |
|
2003 Other Outputs Beta-sheet mimetics and composition and methods relating theretoOgbu, Cyprian O., Kim, Hwa-Ok and Blaskovich, Mark, A. (2003). Beta-sheet mimetics and composition and methods relating thereto. WO/2003/068237. |
